Tech Company Financing Transactions

Epirium Funding Round

On 12/19/2019, Epirium raised $85 million in Series A funding from Adams Street Partners, Arch Venture Partners and Bluebird Ventures.

Transaction Overview

Company Name
Announced On
12/19/2019
Transaction Type
Venture Equity
Amount
$85,000,000
Round
Series A
Proceeds Purpose
The proceeds will be used to further the development of the company's innovative scientific platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4110 Campus Point Ct.
San Diego, CA 92121
USA
Phone
Undisclosed
Email Address
Overview
We are a clinical stage biopharmaceutical company that has uncovered unique insights into the biology of mitochondrial biogenesis and function, leading to an advanced understanding of its pleotropic clinical effect in disease.
Profile
Epirium LinkedIn Company Profile
Social Media
Epirium Company Twitter Account
Company News
Epirium News
Facebook
Epirium on Facebook
YouTube
Epirium on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Russell Cox
  Russell Cox LinkedIn Profile  Russell Cox Twitter Account  Russell Cox News  Russell Cox on Facebook
Chief Scientific Officer
George Schreiner
  George Schreiner LinkedIn Profile  George Schreiner Twitter Account  George Schreiner News  George Schreiner on Facebook
Chief Technical Officer
Sundeep Dugar
  Sundeep Dugar LinkedIn Profile  Sundeep Dugar Twitter Account  Sundeep Dugar News  Sundeep Dugar on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/19/2019: Neurable venture capital transaction
Next: 12/19/2019: Emilio Health venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to record tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary